Literature DB >> 9561384

In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

A Dhondt1, R Vanholder, M A Waterloos, G Glorieux, R De Smet, S Ringoir.   

Abstract

Phagocytosis is an important part of the host defense against infection. Antibiotics can influence phagocytic function. In the present study, leukocyte metabolic response to phagocytic challenge by latex was assessed in relation to in vitro addition of cotrimoxazole, imipenem/cilastatin, cefodizime, dexamethasone (DXM), and/or cyclosporin A (CsA). Using latex particles as phagocytic challenge, glucose-1-14C utilization and 14CO2 production were measured by liquid scintillation counting. The phagocytic response was impaired by in vitro addition of DXM or CsA and this setup was used as an experimental model of immunodepression. The addition of co-trimoxazole to control samples (without DXM or CsA) depressed the response to latex challenge, whereas imipenem and cefodizime had a neutral effect. In the presence of DXM, co-trimoxazole induced a further decrease. The depressive effect of DXM was partially neutralized in the presence of cefodizime. With CsA depression, co-trimoxazole also induced a further decrease, imipenem had a neutral effect, while cefodizime partially restored the CsA suppressed reaction. Co-trimoxazole depressed the phagocytic response, imipenem had a neutral effect, whereas cefodizime restored the experimentally induced immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561384     DOI: 10.1007/BF02767775

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  68 in total

Review 1.  Cefodizime as a biological response modifier: a review of its in-vivo, ex-vivo and in-vitro immunomodulatory properties.

Authors:  M T Labro
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

Review 2.  The in-vitro activity of cefodizime: a review.

Authors:  C J Soussy; M Chanal; M D Kitzis
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

3.  In vitro and ex vivo enhancement of nonspecific phagocytosis by cefodizime.

Authors:  A Fietta; C Bersani; R Bertoletti; F M Grassi; G G Grassi
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

4.  Cyclosporin A for psoriasis.

Authors:  W Mueller; B Herrmann
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

Review 5.  Effect of antibiotics on the immune response.

Authors:  W E Hauser; J S Remington
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

6.  Effects of antibacterial agents on the elimination of 32P-labelled Escherichia coli by human polymorphonuclear cells (PMN).

Authors:  K Melby; T Midtvedt
Journal:  Acta Pathol Microbiol Scand B       Date:  1981-04

7.  Stimulatory effect of cefodizime on macrophage-mediated phagocytosis.

Authors:  K Oishi; K Matsumoto; M Yamamoto; T Morito; T Yoshida
Journal:  J Antibiot (Tokyo)       Date:  1989-06       Impact factor: 2.649

8.  Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.

Authors:  C Hennequin; B Page; P Roux; C Legendre; H Kreis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

9.  In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results.

Authors:  E Mini; A Novelli; M Coronnello; S Fallani; A Pesciullesi; P Periti
Journal:  J Chemother       Date:  1993-12       Impact factor: 1.714

Review 10.  Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.

Authors:  C Ponticelli; P Passerini
Journal:  Clin Nephrol       Date:  1991       Impact factor: 0.975

View more
  1 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.